Biotechnology company developing viral immunotherapies that turn cancer cells into biofactories, initially targeting glioblastoma, an aggressive form of brain cancer
Biotechnology company developing viral immunotherapies that turn cancer cells into biofactories, initially targeting glioblastoma, an aggressive form of brain cancer. Its technology was developed at UCSF.